Search results - 19 results
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
the cobas 4800 HPV test (cobas). The panel comprises 1,300 stored samples that were obtained from women 25 to 64 years old who participated in the Slovenian cancer screening program, enriched with 300 ...
The use of the permanent sample (eps) to study the returnto- work after cancer. Challenges and opportunities for research
multidisciplinary consultation (MOC) in 2011. RESULTS: By the end of follow-up, 24 % of the workers were deceased. Among those who survived 26 % are unable to work, 12 % are unemployed and 63 % do not receive any ...
Offering Self-Sampling Kits for HPV Testing to Reach Women Who Do Not Attend in the Regular Cervical Cancer Screening Program.
cervical cancer screening, with cytology triage for those with a positive HPV test. The new Dutch program includes sending self-sampling devices to women who do not respond to an invitation to have ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
classified with cervical intraepithelial neoplasia (CIN) grade 2+ (CIN2 +) (n = 102) or CIN3 + (n = 55) within the previous 18 months. Controls were women who had normal cytology results over two subsequent ...
Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models.
from the WHO mortality database together with population data for Belgium and the Netherlands. Different ICD (International Classification of Diseases) were used over time for death cause certification. ...
Evaluatie van maatregelen genomen in de strijd tegen kanker 2016
kankerbeleid, bestaande uit de 7 inhoudelijke domeinen van kankerbeleid. Deze indeling is gebaseerd op de structuur zoals voorgesteld door de Wereldgezondheidsorganisatie (WHO), de International Union Against ...
Evaluatie van maatregelen genomen in de strijd tegen kanker 2016
kankerbeleid, bestaande uit de 7 inhoudelijke domeinen van kankerbeleid. Deze indeling is gebaseerd op de structuur zoals voorgesteld door de Wereldgezondheidsorganisatie (WHO), de International Union Against ...
Fostering Collaboration for Paediatric Demand-Driven Innovation: Insights and Strategies from the ADD4KIDS Working Group
initiative is the belief that innovation is not just about developing new technologies—it is about ensuring that those technologies reach the children who need them. Hospitals do not lack innovative solutions; ...
Clinical Guidance: Supporting the introduction of the HPV test in cervical cancer screening in Belgium
Organisation (WHO) (5, 6) and the International Agency for Research on Cancer (IARC) (7). Moreover, adolescents (girls and boys) are vaccinated against the human papillomavirus through vaccination programmes ...